StockData
Boundless Bio, Inc. logo

Boundless Bio, Inc. (BOLD) stock

BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.50+0.04 (+1.63%)

Close on Nov 13, 2026Market cap $56.87MP/E –Yield –

Boundless Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Boundless Bio's market cap was $55.29M on Nov 11, 2026, against $26.19M a year earlier. Over the last 3 years it ranged from $12.36K to $80.56M, with a median of $32.49M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$55.29M+105.8%
2025Dec 31, 2025$26.86M-58.4%
2024Dec 31, 2024$64.54M–

More Boundless Bio figures

See a number that looks wrong?